首页> Dermatologic therapy.> Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies

Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies

导出原文传递

翻译打印收藏纠错

第一作者： Andrea Conti

作者： Andrea Conti ^[1] ; Giovanni Damiani ; Roberta Ruggeri ; Giulia Odorici ; Francesca Farnetani ; Paolo Daniele Maria Pigatto

作者单位： Dermatologic Unit, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy ^[1]

关键词 biologics COVID-19 pandemic infliximab interclass switching intraclass switching psoriasis switching teledermatology

发布时间 2022-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Dermatologic therapy.

2021年34卷5期

e15088-e15088页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Dermatologic therapy.

2021年34卷5期

e15088-e15088页

检索历史清除

Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies

Dermatologic therapy.

相似文献

同项目论文

Dermatologic therapy.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Switching infliximab in psoriatic patients during COVID-19 pandemics: A real-life retrospective study comparing intra-versus interclass switching strategies

Dermatologic therapy.

相似文献

同项目论文

Dermatologic therapy.

相关期刊

检索历史清除